Check out Industry Peers
| Peers & Returns | 1W | 1M | 1Y |
| PANACEA BIOTEC | -12.3% | -1.2% | 26.4% |
| BIOCON | -4.2% | 9.4% | 85.1% |
| Returns | 1W : -12.3% , 1M : -1.2%,1Y : 26.4% |
| Peers & Returns | 1W | 1M | 1Y |
| PANACEA BIOTEC | -12.3% | -1.2% | 26.4% |
| BIOCON | -4.2% | 9.4% | 85.1% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S PEG |
96.05 6.11 5.75 - |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
123% 2018% 1466% |
| Year | Debt/Equity ratio | |
|---|---|---|
|
Debt/Equity ratio analysis
For Banking industry, Good = Ratio less than 13 Average = Ratio between 13 and 15 Bad = Ratio greater than 15 For all non-Banking industries, Good = Ratio less than 0.4 Average = Ratio between 0.4 and 0.6 Bad = Ratio greater than 0.6 Worst is considered between Standalone & Consolidated |
Standalone | Consolidated |
|
2019 2018 2017 Avg_3yrs |
1.65 2.5 2.24 2.13 |
1.85 3.05 2.79 2.56 |
|
[Last Annual Data : Mar2019]
|
||
| Pledged Shares |
69.36 % |
|---|---|
| As of : July 14,2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
| Parameter | 1 Qtr Growth | 4 Qtr Growth |
|---|---|---|
|
Revenue Op Profit EBIDT Net Income |
34.72% -79.77% 22.36% -50.64% |
208.14% -103.09% -56.94% -62% |
| QtrlyTrend |
-2
Quarterly Trend analysis
The growth rate score are assigned as under: If ratio's 1Q growth is +ve, then 1. If -ve, then -1. If ratio's 4Q growth is +ve, then 1.If -ve, then -1. Growth Score= Sum of all the above scores for Revenue, Operating Profit and Net Income. Interpretation Good = Growth Score >=4 Neutral = Growth Score between 0 and 4 Bad = Growth Score less than 0 |
|
| Latest Qtr: Jun2020 | ||
|
Financials of BIOCON LTD |
